Sandrine Macé

1 ta ish

Sanofi (France)

1. Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

   Haibo Sun, Thomas G. Martin, John Donald Marra +7

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.296886